SD Biosensor, Inc. (137310.KS)
KSE · KRW · Healthcare · Medical Devices
₩6,250 (-0.16%) as of
Key statistics
- Market cap
- 747.62B
- Dividend yield
- 3.15%
- 52-week range
- 5,800.00 – 10,180.00
- Beta
- 0.70
- Revenue (TTM)
- 738.76B
- Profit margin
- -98.75%
- Volume
- 53.70k
About SD Biosensor, Inc.
SD Biosensor, Inc., together with its subsidiaries, operates as an in-vitro diagnostic company in South Korea, India, Asia, Europe, the Americas, and Africa. The company offers STANDARD Q, which provides rapid diagnostic products; STANDARD F, a fluorescence immunodiagnostic system for various qualitative and quantitative diagnosis items; STANDARD E, an enzyme immunoassay diagnosis for large-volume tests; and STANDARD M, a field molecular diagnosis system for infectious disease diagnosis, drug resistance, and genetic testing. It also provides STANDARD i, an analyzer based on chemiluminescence immunoassay technology for detection of clinical biomarkers, including hormones, tumor markers, and infectious diseases; blood glucose meter products; and other products, such as transport medium, d-BLOCK incubator, G6PD analyzer, LipidoCare analyzer, MultiCare analyzer, and Pilot COVID-19 at-home test. The company exports its products. SD Biosensor, Inc. was founded in 1999 and is headquartered in Suwon-si, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Suwon-si, South Korea
- Employees
- 616
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.